Rituximab Protects Insulin Producing Cells in Diabetes (CME/CE)
Patients with new-onset type 1 diabetes were modestly better able to retain beta cell function after treatment with the B-cell depleting agent rituximab (Rituxan), researchers said.
source : www.medpagetoday.com
How DUMB are YOU?!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Related News:
- Greater Infection Risk with Staples in Hip Surgery (CME/CE)
- ACC: Radial Artery Matches Saphenous Vein for CABG (CME/CE)
- SIR: Combo of Embolization and Bevacizumab Safe (CME/CE)
- SIR: Cryotherapy Effective in Soft Tissue (CME/CE)
- SGO: HPV Vaccine Stops Recurrence After Surgery (CME/CE)
- SGO: No Lung CA Risk Seen with Estrogen (CME/CE)
- SSRI, Naltrexone, Talk Therapy Keep Depressed Alcoholics Dry (CME/CE)
- Gaps Remain in Cancer Palliative Care (CME/CE)
- ACC: No Benefit from Ventricular Reconstruction (CME/CE)
- ACC: Intensive Statin Tx Cuts CVEs in Kidney Disease Patients (CME/CE)
Details :
Submited at Wednesday, November 25th, 2009 at 7:01 pm on Cardiology by chuck
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...